Long-term Consequences of Genital HPV Infections in Women

References

• Papillomaviruses and Human Disease, K Syrjänen, L Gissmann, L. G. Koss. Springer Verlag, Heidelberg 1987; 1–518
   Google Scholar
• zur Hausen H. Viruses and human cancer. Science 1991; 254: 1167–73
   PubMed Web of Science ®Google Scholar
• Franco E L. Viral etiology of cervical cancer: a critique of the evidence. Rev Infect Dis 1991; 13: 1195–206
   PubMedGoogle Scholar
• zur Hausen H. Papillomavirus in anogenital cancer: the dilemma of epidemiologic approaches. J Nat Cancer Inst 1989; 81: 1681–2
   Google Scholar
• Syrjänen K J. Natural history of genital HP infections. Papillomavirus Rep 1990; 1(4)1–5
   Google Scholar
• Kataja V, Syrjänen K, Mäntyjärvi R, Väyrynen M, Syrjänen S, Saarlkoskl S, Parkkinen S, Yliskoski M, Salonen J T, Castren O. Prospective follow‐up of cervical HPV infections. Life‐table analysis of histopathological, cytological and colposcopic data. Eur J. Epidemiol 1989; 5: 1–8
   PubMed Web of Science ®Google Scholar
• Kataja V, Syrjänen S, Yliskoski M, Parkkinen S, Saarikoski S, Mäntyjärvi R, Väyrynen M, Salonen J T, Castren O. Prospective follow‐up of genital HPV infections. Life‐table analysis of HPV typing data. Eur J Epidemiol 1990; 6: 9–14
   PubMed Web of Science ®Google Scholar
• Kataja V, Syrjänen K, Syrjänen S, Mäntyjärvi R, Yliskoski M, Saarikoski S, Salonen J T. Prognostic factors in cervical human papillomavirus (HPV) infections. Sex Transm Dis 1992, in press
   PubMed Web of Science ®Google Scholar
• Syrjänen K J. Epidemiology of human papillomavirus (HPV) infections and their associations with genital squamous cell cancer. APMIS 1989; 97: 957–70
   PubMed Web of Science ®Google Scholar
• Syrjänen K, Syrjänen S. Epidemiology of human papilloma virus infections and genital neoplasia. Scand J Infect Dis 1990, Suppl 69: 7–17
   Google Scholar
• Wickenden C, Malcolm A DB, Steele A, Coleman D V. Screening for wart virus infection in normal and abnormal cervices by DNA hybridization of cervical scrapes. Lancet 1985; 1: 65–7
   PubMed Web of Science ®Google Scholar
• Macnab J CM, Walkinshaw S A, Cordiner J W, Clements J B. Human papillomavirus in clinically and histologically normal tissue of patients with genital cancer. N Engl J. Med 1986; 315: 1052–8
   PubMed Web of Science ®Google Scholar
• Kellokoski J. Human papillomavirus (HPV) infections of the oral cavity in women with genital HPV infections. Kuopio University Publications B. Dental Services 1992; 1: 1–92
   Google Scholar
• Schneider A. Latent and subclinical genital HPV infections. Papillomavirus Rep 1990; 1(3)2–5
   Google Scholar
• Hippeläinen M, Yliskoski M, Saarlkoski S, Syrjänen S, Syrjänen K. Genital human papillomavirus lesions of the male sexual partners: the diagnostic accuracy of penis‐copy. Genitourin Med 1991; 67: 291–6
   PubMedGoogle Scholar
• Syrjänen K, Kataja V, Yliskoski M, Chang F, Syrjänen S, Saarikoski S. Natural history of cervical HPV lesions with special emphasis on the biologic relevance of the Bethesda System. Obstet Gynecol 1992; 79: 675–82
   PubMed Web of Science ®Google Scholar
• Syrjänen S, Syrjänen K. Human papillomavirus (HPV) infections of the genital tract Clinical significance and diagnosis by PCR. Frontiers in Virology: Diagnosis of Human Viruses by Polymerase Chain Reaction (PCR) Technology, Y Becker, G Darai. Springer‐Verlag, Heidelberg 1992, in press
   Google Scholar
• Roman A, Fife K H. Human papillomaviruses: are we ready to type. Clin Microbiol Rev 1989; 2: 166–90
   PubMed Web of Science ®Google Scholar
• Syrjänen K, Hakama M, Saarikoski S, Väyrynen M, Yliskoski M, Syrjänen S, Kataja V, Castren O. Prevalence, incidence and estimated life‐time risk of cervical human papillomavirus (HPV) infections in nonselected. Finnish female population. Sex Transm Dis 1990; 17: 15–19
   PubMed Web of Science ®Google Scholar
• Yliskoski M, Saarikoski S, Syrjänen K. Conization for CIN associated with human papillomavirus infection. Arch Gynecol Obstet 1991; 249: 59–65
   PubMed Web of Science ®Google Scholar
• Yliskoski M, Syrjänen K, Syrjänen S, Saarikoski S, Nethersell A. Systemic α‐interferon (WellferonB) treatment of genital human papillomavirus (HPV) type 6, 11, 16 and 18 infections. Double‐blind, placebo‐controlled trial. Gynecol Oncol 1991; 43: 55–60
   PubMedGoogle Scholar
• Syrjänen K, Yliskoski M, Kataja V, Hippeläinen M, Syrjänen S, Saarikoski S, Ryhänen A. Prevalence of genital human papillomavirus (HPV) infections in a massscreened Finnish female population aged 20–65 years. Int J STD & AIDS 1990; 1: 410–15
   PubMedGoogle Scholar
• Kataja V, Syrjänen S, Yliskoski M, Hippeläinen M, Väyrynen M, Saarikoski S, Mäntyjärvi R, Jokela V, Salonen J T, Syrjänen K. Risk factors associated with cervical human papillomavirus (HPV) infections: a case‐control study. Am J. Epidemiol 1992, submitted and revised
   Web of Science ®Google Scholar
• Syrjänen K, Nurmi T, Mäntyjärvi R, Ilonen J, Syrjänen S, Surcel H ‐M., Yliskoski M, Väyrynen M, Saarikoski S. HLA types in women with human papillomavirus (HPV)‐associated cervical precancer lesions with established natural history. Nature 1992, submitted
   Google Scholar